Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
We send one confirmation email first. Only emails about CBIH, unsubscribe in one click. Privacy
CBIH reported $90 in cash and short-term investments (as of Feb 28, 2026) and used about $41,381/quarter in operations, an estimated runway of 0 months at that rate (BioRadar estimate, not company guidance).
Dilution pressure: 40 · Elevated
Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when CBIH files for a raise →
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for CBIH and every other ticker you follow. Card required, cancel anytime.
Start 7-day free trial →